105 related articles for article (PubMed ID: 20332751)
1. Review: extramedullary disease in multiple myeloma.
Madan S; Kumar S
Clin Adv Hematol Oncol; 2009 Dec; 7(12):802-4. PubMed ID: 20332751
[No Abstract] [Full Text] [Related]
2. Unusual multiple myeloma cutaneous manifestation following nonmyeloablative allogeneic stem cell transplantation.
Subbiah S; O'Connell F; Kobraei KB; Ramos-Caro FA; Moreb JS
Clin Adv Hematol Oncol; 2009 Dec; 7(12):800-2. PubMed ID: 20332750
[No Abstract] [Full Text] [Related]
3. [Multiple myeloma with cutaneous involvement in a patient with long-standing MGUS].
Giraldo MP; Delgado MP; Rubio Félix D
Sangre (Barc); 1993 Apr; 38(2):156-7. PubMed ID: 8516731
[No Abstract] [Full Text] [Related]
4. Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.
Ayuk F; Perez-Simon JA; Shimoni A; Sureda A; Zabelina T; Schwerdtfeger R; Martino R; Sayer HG; Alegre A; Lahuerta JJ; Atanackovic D; Wolschke C; Nagler A; Zander AR; San Miguel JF; Kröger N
Haematologica; 2008 Sep; 93(9):1343-50. PubMed ID: 18641030
[TBL] [Abstract][Full Text] [Related]
5. Multiple myeloma with cutaneous dissemination.
Ramachandran KA; Duggal RK
J Assoc Physicians India; 2000 Jun; 48(6):652-3. PubMed ID: 11273553
[No Abstract] [Full Text] [Related]
6. Extramedullary gastric plasmacytoma.
Hamilton JW; McCluggage WG; Jones F; Collins J
Ulster Med J; 1999 Nov; 68(2):103-5. PubMed ID: 10661638
[No Abstract] [Full Text] [Related]
7. Cutaneous manifestations of multiple myeloma.
Kois JM; Sexton FM; Lookingbill DP
Arch Dermatol; 1991 Jan; 127(1):69-74. PubMed ID: 1986709
[TBL] [Abstract][Full Text] [Related]
8. Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome.
Minnema MC; van de Donk NW; Zweegman S; Hegenbart U; Schonland S; Raymakers R; Zijlmans JM; Kersten MJ; Bos GM; Lokhorst HM
Bone Marrow Transplant; 2008 May; 41(9):779-84. PubMed ID: 18195681
[TBL] [Abstract][Full Text] [Related]
9. Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome.
Zeiser R; Deschler B; Bertz H; Finke J; Engelhardt M
Bone Marrow Transplant; 2004 Dec; 34(12):1057-65. PubMed ID: 15516937
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma triggered by endogenous HHV-8 reactivation after non-myeloablative allogeneic haematopoietic transplantation.
Bruno B; Sorasio R; Barozzi P; Vieira J; Omedè P; Giaretta F; Rotta M; Giaccone L; Massaia M; Luppi M; Boccadoro M
Eur J Haematol; 2006 Apr; 76(4):342-7. PubMed ID: 16519707
[TBL] [Abstract][Full Text] [Related]
11. [Arndt-Gottron scleromyxedema and associated phenomena].
Lang E; Zabel M; Schmidt H
Dermatologica; 1984; 169(1):29-35. PubMed ID: 6432594
[TBL] [Abstract][Full Text] [Related]
12. Extramedullary plasmacytoma of skin, bowel and bladder.
Gesme D; Boatman D; Weinman G; Tewfik H
Iowa Med; 1994 Aug; 84(8):354-5. PubMed ID: 7960638
[No Abstract] [Full Text] [Related]
13. Extramedullary relapse of multiple myeloma presenting as hematemesis and melena.
Dawson MA; Polizzotto MN; Gordon A; Roberts SK; Spencer A
Nat Clin Pract Oncol; 2006 Apr; 3(4):223-6; quiz 227. PubMed ID: 16596146
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of thalidomide therapy for extramedullary relapse of myeloma following allogeneic transplantation.
Biagi JJ; Mileshkin L; Grigg AP; Westerman DW; Prince HM
Bone Marrow Transplant; 2001 Dec; 28(12):1145-50. PubMed ID: 11803357
[TBL] [Abstract][Full Text] [Related]
15. The relationship between proliferation and apoptosis in patients with monoclonal gammopathy of undetermined significance or multiple myeloma.
Scudla V; Ordeltova M; Bacovsky J; Vytrasova M; Horak P; Minarik J
Haematologica; 2005 Dec; 90(12):1713-4. PubMed ID: 16330455
[TBL] [Abstract][Full Text] [Related]
16. Multiple myeloma with cutaneous involvement.
Tschen JA; Migliore PJ; McGavran MH
Arch Dermatol; 1980 Dec; 116(12):1394. PubMed ID: 7006516
[No Abstract] [Full Text] [Related]
17. Isotype class switching after transplantation in multiple myeloma.
Maisnar V; Tichý M; Smolej L; Zák P; Radocha J; Palicka V; Malý J; Bláha V
Neoplasma; 2007; 54(3):225-8. PubMed ID: 17447854
[TBL] [Abstract][Full Text] [Related]
18. Multiple myeloma first observed as multiple cutaneous plasmacytomas.
Shah A; Klimo P; Worth A
Arch Dermatol; 1982 Nov; 118(11):922-4. PubMed ID: 6814367
[TBL] [Abstract][Full Text] [Related]
19. [Relapse of multiple myeloma in extramedullary sites].
Bairey O; Huminer D; Blickstein D; Sandbank Y; Shaklai M
Harefuah; 1993 May; 124(9):539-41, 600. PubMed ID: 8340001
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation.
Patriarca F; Prosdocimo S; Tomadini V; Vasciaveo A; Bruno B; Fanin R
Haematologica; 2005 Feb; 90(2):278-9. PubMed ID: 15710593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
